The nearest restaurant of any note is Chez Bruce. Curiously enough for such an Australian name, Chez Bruce is very highly rated. We could all meet there! We could invite Zoe Downes, Visiongain's chief pharmaceutical analyst. She could explain quite how rich we're all going to become. The treat's on me!
Bye, bye all. I'm off to the Far East. I won't be back until the end of January.
Who knows what the future holds for us? I'm optimistic but, over the six years I've been involved, GW has proven to be a capricious friend.
GW closed on the first trading day of 2005 at 118.5p. With luck it'll match that on the last trading day of 2005. GW has made huge net progress since 4/1/05. It has a great new partner. It has plenty of cash. It is near to completing the Phase III trial that will guarantee MHRA approval (and I do mean guarantee). It may be close to an IND. It has great data on rheumatoid arthritis palliation (maybe even a cure), but it's worth no more than a nearly year ago.
I have great hopes for GW. The best of luck and a Happy New Year to all of us.
GW Pharm stock quotes
GW Pharm stock charts
Follow this thread
